Japanese DFPP / 日机双重血液净化
Device Class
Selective lipid adsorption and double filtration plasmapheresis system
Intended Use
Selective low-density lipoprotein (LDL) adsorption, microvascular circulation improvement, and pathogenic factor removal.选择性低密度脂蛋白 (LDL) 吸附、改善微血管循环及体内致病因子清除。
What This Means For Patients
An advanced Japanese selective lipoprotein adsorption system optimized for targeted cholesterol clearing and vascular cleansing, approved by PMDA and FDA.日本先进的选择性脂质吸附与血浆成分过滤系统。专门用于靶向低密度脂蛋白(LDL)清除,已获日本 PMDA 和美国 FDA 批准。
Regulatory Approvals
Not yet documented.
This page provides regulatory and mechanism-of-action information for reference only. It is not medical advice, a treatment recommendation, or a guarantee of outcome. Availability is subject to individual clinical review.